$1.53 EPS Expected for Walgreens Boots Alliance, Inc. (WBA)

March 14, 2018 - By Clifton Ray

 $1.53 EPS Expected for Walgreens Boots Alliance, Inc. (WBA)

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.53 EPS on April, 4.They anticipate $0.17 EPS change or 12.50 % from last quarter’s $1.36 EPS. WBA’s profit would be $1.52B giving it 11.42 P/E if the $1.53 EPS is correct. After having $1.28 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see 19.53 % EPS growth. The stock decreased 0.41% or $0.29 during the last trading session, reaching $69.86. About 4.52M shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has risen 5.77% since March 14, 2017 and is uptrending. It has underperformed by 10.93% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 22 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Walgreens Boots Alliance had 55 analyst reports since August 24, 2015 according to SRatingsIntel. Jefferies maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on Friday, October 27 with “Buy” rating. The firm earned “Buy” rating on Thursday, October 26 by Loop Capital. Credit Suisse maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) rating on Monday, July 18. Credit Suisse has “Outperform” rating and $82.51 target. The firm has “Buy” rating by Needham given on Tuesday, November 21. The firm earned “Buy” rating on Wednesday, January 24 by Mizuho. SunTrust maintained the stock with “Hold” rating in Friday, October 13 report. On Tuesday, September 5 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating by Needham given on Monday, July 17. The stock has “Underperform” rating by Wood on Friday, July 22. The firm earned “Outperform” rating on Thursday, September 1 by Credit Suisse.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $69.21 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 19.27 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More important recent Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news were published by: Businesswire.com which released: “Rite Aid Announces Continued Progress in Sale of Assets to Walgreens Boots …” on March 05, 2018, also Seekingalpha.com published article titled: “Walgreens Boots Alliance appoints James Kehoe Global CFO”, Zacks.com published: “Should Value Investors Pick Walgreens Boots Alliance (WBA) Stock?” on February 27, 2018. More interesting news about Walgreens Boots Alliance, Inc. (NASDAQ:WBA) was released by: Seekingalpha.com and their article: “Walgreens Boots Alliance – What Keeps The Stock From Going Up?” with publication date: March 12, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.